AllianceBernstein
PLSE icon

AllianceBernstein’s Pulse Biosciences PLSE Stock Holding History

AllianceBernstein’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$449K Buy
20,800
+7,900
+61% +$186K ﹤0.01% 2789
2026
Q1 		$177K Sell
12,900
-7,720
-37% -$142K ﹤0.01% 3074
2025
Q4 		$283K Hold
20,620
– – ﹤0.01% 2939
2025
Q3 		$365K Buy
20,620
+1,300
+7% +$20.6K ﹤0.01% 2851
2025
Q2 		$292K Buy
19,320
+6,400
+50% +$106K ﹤0.01% 2925
2025
Q1 		$208K Sell
12,920
-1,580
-11% -$29.5K ﹤0.01% 2912
2024
Q4 		$252K Hold
14,500
– – ﹤0.01% 2955
2024
Q3 		$254K Buy
14,500
+2,680
+23% +$45.7K ﹤0.01% 2978
2024
Q2 		$132K Buy
+11,820
New +$111K ﹤0.01% 3088
2022
Q2 		– Sell
-21,349
Closed -$104K – 3352
2022
Q1 		$104K Sell
21,349
-1,500
-7% -$12.3K ﹤0.01% 3111
2021
Q4 		$338K Hold
22,849
– – ﹤0.01% 2912
2021
Q3 		$494K Hold
22,849
– – ﹤0.01% 2766
2021
Q2 		$375K Buy
22,849
+1,000
+5% +$19K ﹤0.01% 2931
2021
Q1 		$517K Sell
21,849
-3,600
-14% -$108K ﹤0.01% 2645
2020
Q4 		$607K Hold
25,449
– – ﹤0.01% 2501
2020
Q3 		$300K Buy
25,449
+225
+0.9% +$2.42K ﹤0.01% 2810
2020
Q2 		$264K Buy
25,224
+8,624
+52% +$77.7K ﹤0.01% 2933
2020
Q1 		$119K Buy
16,600
+1,400
+9% +$14.5K ﹤0.01% 2921
2019
Q4 		$204K Hold
15,200
– – ﹤0.01% 2913
2019
Q3 		$235K Sell
15,200
-100
-0.7% -$1.3K ﹤0.01% 2886
2019
Q2 		$202K Buy
15,300
+500
+3% +$6.82K ﹤0.01% 2966
2019
Q1 		$260K Buy
14,800
+3,000
+25% +$47.1K ﹤0.01% 2815
2018
Q4 		$135K Hold
11,800
– – ﹤0.01% 2955
2018
Q3 		$167K Buy
11,800
+600
+5% +$8.53K ﹤0.01% 3014
2018
Q2 		$170K Sell
11,200
-700
-6% -$11.8K ﹤0.01% 3001
2018
Q1 		$161K Buy
11,900
+1,400
+13% +$26.6K ﹤0.01% 2903
2017
Q4 		$248K Buy
+10,500
New +$248K ﹤0.01% 2787

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

AllianceBernstein's PLSE Position: Q2 2026 in Review

AllianceBernstein increased its Pulse Biosciences (PLSE) stake by 61% in Q2 2026, buying an estimated $186K and bringing the position to 20,800 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #2789.

AllianceBernstein first reported a position in PLSE in Q4 2017 and has held it in 27 quarters since. The position peaked at $607K in Q4 2020. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • AllianceBernstein held 20,800 shares of Pulse Biosciences worth $449K as of Q2 2026.
  • AllianceBernstein bought 7,900 Pulse Biosciences shares in Q2 2026, an estimated $186K.
  • Pulse Biosciences made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2789 holding.
  • AllianceBernstein first reported a position in Pulse Biosciences in Q4 2017 and has held it in 27 quarters since.
  • AllianceBernstein's Pulse Biosciences position peaked at $607K in Q4 2020.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.